Hansoh Pharmaceutical: Share capital unchanged in October

Hansoh Pharmaceutical Group Company Limited has submitted its monthly return for October 2025, revealing no changes in its authorized or issued share capital during the period. The total authorized/registered share capital remains at 20,000,000,000 shares with a par value of HK$0.00001, totaling HK$200,000. The number of issued shares also held steady at 6,055,150,070, with no treasury shares recorded.

The company's "Zero coupon convertible bonds due 2026," issued on January 22, 2021, maintained an amount of $5,378,000 at the close of the month. These convertibles, with a subscription/conversion price of HK$56.7, could potentially result in 735,363 new shares being issued. No new shares were issued from these convertibles during October 2025.